Helicos to Cut 14 More Positions; Lapidus Steps Down as Chairman | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Helicos BioSciences said Tuesday after the close of the market that as part of its ongoing restructuring plan it will cut another 14 positions from the firm as it aims to reduce its operating costs.

In addition, it disclosed that Chairman Stanley Lapidus has stepped down from his post but will remain a member of the board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.

The San Diego Union-Tribune takes a look at the work to be done in personalized medicine.

An op-ed in the Wall Street Journal calls for the establishment of a patent court staffed by judges and experts with science backgrounds.

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.